CVS Health: Why I'm Not Buying The Post-Earnings Share Buoyancy

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.CVS Health Corporation (NYSE: CVS ) announced its Q1 2025 earnings earlier today, and the market's response appears to be very positive - shares are up >7% at the time of w ...